Physician profile
Richard Dalyai
NPI 1689818346
$48,961.39
in general payments reported to CMS, 2019-2025
27 companies · $2,560 in 2025
The $2,560 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,913 · 2020: $1,390 · 2021: $2,916 · 2022: $8,319 · 2023: $17K · 2024: $12K · 2025: $2,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $9,540 · Travel and Lodging: $7,170 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,692.75 |
| Food and Beverage | $9,540.46 |
| Travel and Lodging | $7,170.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $10,324.48 | 2019-2025 | Penumbra System, Red 72, Benchmark |
| Scientia Vascular | $9,227.53 | 2022-2025 | Socrates 38 |
| Medical Device Business Services, INC. | $6,596.64 | 2024 | Emboguard |
| Depuy Synthes Products, INC. | $4,865.62 | 2022 | |
| Imperative Care, INC | $4,481.22 | 2021-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter, Zoom Rdl Radial Access System, 103cm |
| Medtronic USA, INC. | $3,248.63 | 2019-2020 | |
| Depuy Synthes Sales INC. | $2,849.60 | 2019-2025 | Embotrap, Cerepak Uniform, Trufill |
| Stryker Corporation | $2,136.59 | 2019-2024 | Power-Pro, Target, Surpass Evolve |
| Corindus INC. | $981.12 | 2019 | |
| Rapid Medical Ltd | $941.21 | 2022-2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Irras USA, INC. | $819.21 | 2020-2024 | |
| Longeviti Neuro Solutions INC | $585.04 | 2021-2023 | |
| Medtronic, INC. | $443.96 | 2021-2025 | Pipeline, Solitaire X, Axium Primetm |
| Microvention, INC. | $378.87 | 2019-2021 | |
| Route 92 Medical, INC. | $317.04 | 2023-2024 | 8f Base Camp Sheath System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synaptive Medical INC. | $237.39 | 2021 | |
| Siemens Medical Solutions USA, INC. | $169.40 | 2021-2022 | |
| Providence Medical Technology, INC. | $88.08 | 2023 | |
| Balt USA, LLC | $75.04 | 2022 | |
| Baxter Healthcare | $54.92 | 2021-2024 | Floseal |
| Si-Bone, INC. | $38.85 | 2019 | |
| Cardiva Medical, INC. | $35.11 | 2020 | |
| Csl Behring | $20.00 | 2023 | Kcentra |
| Qapel Medical INC | $19.41 | 2023 | |
| Abbott Laboratories | $13.36 | 2023 | Infinity |
| Boston Scientific Corporation | $13.07 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Dalyai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.